Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.66 EUR | -2.14% | -2.14% | -19.03% |
Apr. 02 | Shedir Pharma, into 2023 with rising revenues; profit down single digits | AN |
Mar. 29 | Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 63M 67.11M | Sales 2025 * | 67.7M 72.12M | Capitalization | 42.5M 45.27M |
---|---|---|---|---|---|
Net income 2024 * | 6M 6.39M | Net income 2025 * | 7M 7.46M | EV / Sales 2024 * | 0.45 x |
Net cash position 2024 * | 14.3M 15.23M | Net cash position 2025 * | 23.1M 24.61M | EV / Sales 2025 * | 0.29 x |
P/E ratio 2024 * |
6.34
x | P/E ratio 2025 * |
5.67
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 12.01% |
1 day | -2.14% | ||
1 week | -2.14% | ||
Current month | -8.04% | ||
1 month | -3.68% | ||
3 months | -17.57% | ||
6 months | -20.78% | ||
Current year | -19.03% |
Managers | Title | Age | Since |
---|---|---|---|
Antonio Scala
CEO | Chief Executive Officer | 39 | 13-12-31 |
Giuseppe Somma
IRC | Investor Relations Contact | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marco Mazzarese
BRD | Director/Board Member | 45 | 18-12-31 |
Lucio Fusaro
BRD | Director/Board Member | 68 | 21-12-31 |
Umberto di Maio
FOU | Founder | 51 | 14-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 3.66 | -2.14% | 250 |
24-04-18 | 3.74 | 0.00% | 0 |
24-04-17 | 3.74 | +1.08% | 500 |
24-04-16 | 3.7 | +1.09% | 250 |
24-04-15 | 3.66 | -2.14% | 1,500 |
Real-time Borsa Italiana, April 19, 2024 at 11:44 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.03% | 45.31M | |
+24.87% | 672B | |
+24.08% | 550B | |
-5.86% | 351B | |
+15.58% | 317B | |
+7.24% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.74% | 144B | |
-6.58% | 141B |
- Stock Market
- Equities
- SHE Stock